Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sabratek was a medical technology company that specialized in the development and manufacturing of infusion pumps and remote healthcare monitoring systems. The company's primary products included the Sabratek 3030 and 6060 infusion pumps, designed for use in both hospital and home care settings to deliver fluids and medications. Sabratek also developed software solutions intended to facilitate remote communication between patients and healthcare providers. Despite initial commercial success and a public listing, the company faced significant regulatory challenges from the FDA and internal accounting discrepancies. These issues led to a voluntary recall of its pumps and eventually forced the company into Chapter 11 bankruptcy in 1999. Following the bankruptcy filing, the company's core assets were acquired by Baxter International in 2000.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sabratek.